Ransomware Intelligence

    Latest Research on INC and The Gentlemen Ransomware: Exposed AI Infrastructure

    Read the Research

    FUJIFILM Ransomware Attack

    fujifilm.comRansomed

    sarcomaGroup
    JapanCountry
    Apr 5, 2025Discovered

    Data has been published on the ransomware group's leak site.

    About this victim

    Fujifilm has actively promoted the research and development of liposome formulations by harnessing its advanced nano-dispersion technology, analysis technology, and process technology cultivated and evolved through its wide range of product development. In 2017, the company began a U.S. Phase I clinical trial of FF-10832, a liposome-based agent that encapsulates the approved anti-cancer agent gemcitabine *** . In the preclinical mice studies on FF-10850 and FF-10832 *4 Fujifilm has observed the extension of the survival period as a result of immune checkpoint inhibitor *5 combination therapy. In addition, Fujifilm has been promoting the application of liposome for use with next-generation drugs such as nucleic acid drugs and gene therapy drugs. Looking towards future growth, in order to ensure a stable supply of high-quality liposome formulations, Fujifilm is developing a manufacturing facility for producing investigational and commercial drugs through its subsidiary, FUJIFILM Toyama.Geo: Singapore - Leak size: NO DATA 1 pdf - Contains: NO DATA 1 pdf

    Domain

    fujifilm.com

    Industry

    Technology

    Country

    Japan

    Discovered

    over 1 year ago

    Attack date

    Apr 5, 2025

    Confidence

    100%

    Severity

    Critical

    Status

    Data Leaked

    Threat group

    sarcoma

    Total victims

    89

    First seen

    Nov 2025

    Last seen

    Oct 2026

    Group status

    active

    Sophistication

    0

    Impact score

    70

    Threat level

    3.8/10
    Aggressiveness5/10
    Lethalityn/a
    Criticality2.4/10

    Status breakdown

    Data Leaked
    this victim
    48.3%43
    Claimed51.7%46

    Victim's position within group

    Industry

    Technology

    Known target sector

    Country

    Japan

    Frequently targeted country

    Group activity

    Monthly attacks · sarcoma

    89

    total · avg 22.3/mo